AARP Hearing Center
Hundreds of thousands more low-income older adults will be eligible for financial help to better afford their prescription drugs, under a provision included in the Inflation Reduction Act of 2022.
The new law expands eligibility for Medicare’s Part D Low-Income Subsidy (LIS) benefit, also known as the Part D Extra Help program. Beginning in 2024, Medicare beneficiaries with annual incomes of up to 150 percent of the federal poverty limit ($20,385 for an individual in 2022) who also meet the program’s resources limit can qualify for full benefits under the Extra Help program. The income threshold for full benefits currently is 135 percent of the federal poverty guidelines ($18,347 for an individual in 2022).
The Extra Help program covers annual Part D premiums and deductibles and some copays and coinsurance costs. Individuals are responsible for modest copays for their drugs until their drug costs reach the catastrophic phase of Part D ($7,050 in 2022); after that they don’t pay anything for their medications. As of 2024, any Medicare beneficiary who enters the catastrophic phase will not have to pay anything more for their drugs. Starting in 2025 there will be an annual $2,000 cap on out-of-pocket expenses for everyone who gets their medications through a Part D or Medicare Advantage plan.
More on politics-society
Volunteers Made a Difference in Historic Medicare Vote
Volunteers nationwide asked lawmakers to offer relief from prescription drug pricesPrescription Drug Win Caps AARP’s Yearslong Fight for Lower Prices
The power of tens of millions of 50-plus adults led to a historic victoryHow States Helped Lower Prescription Drug Costs
The sweeping federal bill aimed at cutting drug costs follows years of action at the state level